Elton John AIDS Foundation

Patients

Working in partnership will be key, says Alex Kalomparis, vice president, public affairs, international at Gilead Sciences.

News

Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.